The Coimbra Protocol is a therapeutic intervention which utilizes extremely-high doses of the steroid “vitamin D” to completely suppress disease activity in multiple sclerosis and other autoimmune diseases. This method was carefully developed over years of meticulous research and careful monitoring of patients in a clinical setting. The continuously evolving therapy boasts a 95% success rate in complete disease suppression as well as improvement—and in many cases, reversal of physical disability. Dr. Coimbra is an Associate Professor of Neurology as well as the head of the Laboratory for Clinical Experimental Pathophysiology at the University of São Paulo, Brazil. He is also the President and Founder of the Institute for Investigation and Treatment of Autoimmune Diseases. Together with his team of 8 physicians in his private practice, he has treated over 5,000 patients.
"I think it's quite remarkable that Dr. Coimbra has so many patients that he has treated and that are responding well to his protocol and therapy. This is a good starting point to think about starting clinical research studies that look into high-dose vitamin D for potentially helping patients with autoimmune diseases like multiple sclerosis."
Dr. Michael Holick
Professor of Medicine, Physiology and Biophysics at Boston University School of Medicine
São Paulo, Brazil 2013
Hi, My name is Jenn. I am the first patient in the United States to be treated by the first US protocol doctor using the Coimbra Vitamin D Protocol. There are still millions of people out there suffering from MS and autoimmune diseases. My goal is to help as many as possible learn how to stop this disease using this safe, effective and inexpensive therapy. All the best!